ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 812

Sex Differences in Autoimmunity and Cardiovascular Risk Could Be Associated with Altered Treg Phenotype and Lipoprotein Metabolism

George Robinson1, Kirsty Waddington 1, Anna Radziszewska 1, Hannah Peckham 1, David A Isenberg 2, Yiannis Ioannou 1, Coziana Ciurtin 3, Ines Pineda-Torra 1 and Elizabeth Jury 1, 1University College London, London, United Kingdom, 2Centre for Rheumatology, London, United Kingdom, 3Centre for Adolescent Rheumatology, University College London London, UK, Londond, United Kingdom

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: cardiovascular disease and sex hormones, sex bias, Systemic lupus erythematosus (SLE), T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: 3S077: Pediatric Rheumatology – Basic Science (810–814)

Session Type: ACR Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Males and females have altered immune responses resulting in variation in autoimmune risk. Sex differences exist in the frequency and activity of immune-cell subsets but mechanisms underlying sexual dimorphism remain unknown. Our previous work identified a link between immune cell function and lipid metabolism. We hypothesised that sex hormones could influence immune cell differentiation via changes in lipid metabolism and this could be altered in autoimmune diseases such as juvenile-onset systemic lupus erythematosus (JSLE) that emerges during puberty and has a strong female prevalence.

Methods: Flow cytometry and qPCR were used to measure metabolic marker expression on 44 immune cell subsets from 39 teenage healthy controls (HCs, 17 male, 22 female, mean age 19), 35 age matched JSLE patients (12 male, 23 female, mean age 19), pre puberty HCs (10 males and 10 females, mean age 8) and individuals with gender dysphoria undergoing cross-sex hormone therapy (10 biologic males and 10 biologic females). Analysis of metabolic biomarkers including lipoprotein composition was performed on matching serum using nuclear magnetic resonance.

Results: HC responder (Tresp) and regulatory (Treg) T-cell subsets displayed the strongest immune profile differences by sex with significantly increased Tregs (p= 0.036) and reduced Tresp (p= 0.001) frequencies in males compared to females. HC Male Tregs had an increased suppressive capacity, IL-4 production (p= 0.019) (supported by increased GATA-3 expression) and plasma membrane glycosphingolipid (GSL) expression (p= 0.038) compared to Tregs from HC females. GSL changes were mirrored by increased expression of GSL synthesis enzyme UGCG (p= 0.042) in male Tregs, suggesting a sex-specific alteration in lipid metabolism related to Treg function.

Metabolomic lipoprotein analysis of matching serum revealed that teenage HC males had significantly reduced atheroprotective high density lipoprotein subsets and increased atherogenic very low density lipoprotein (VLDL) subsets compared to HC females. These differences were not observed pre-puberty but were induced appropriately by sex hormone treatment in gender dysphoria individuals; suggesting that sex hormones regulate lipid metabolism in vivo.

VLDL subsets from HC males were preferentially enriched with triglycerides and correlated positively with activated Treg subsets compared to VLDL from HC females where no such relationship was seen. Furthermore, Tregs cultured with VLDL isolated from either HC males or females recapitulated the male and female Treg phenotype respectively. Strikingly, sex differences in Treg frequency, phenotype, lipid metabolism and serum lipoproteins were lost in patients with JSLE. This loss of sexual dimorphism in JSLE patients involved the development of a more atherogenic metabolomic profile and pro-inflammatory T-cell phenotype in females.

Conclusion: Potential defects in sex hormone signalling in patients with JSLE may lead to a loss of differential male/female lipid taxonomy. Defective lipoprotein metabolism in JSLE could alter immune cell plasma membrane lipids and immune cell function and contribute to increased cardiovascular risk in female JSLE patients.


Disclosure: G. Robinson, None; K. Waddington, None; A. Radziszewska, None; H. Peckham, None; D. Isenberg, None; Y. Ioannou, None; C. Ciurtin, None; I. Pineda-Torra, None; E. Jury, None.

To cite this abstract in AMA style:

Robinson G, Waddington K, Radziszewska A, Peckham H, Isenberg D, Ioannou Y, Ciurtin C, Pineda-Torra I, Jury E. Sex Differences in Autoimmunity and Cardiovascular Risk Could Be Associated with Altered Treg Phenotype and Lipoprotein Metabolism [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/sex-differences-in-autoimmunity-and-cardiovascular-risk-could-be-associated-with-altered-treg-phenotype-and-lipoprotein-metabolism/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sex-differences-in-autoimmunity-and-cardiovascular-risk-could-be-associated-with-altered-treg-phenotype-and-lipoprotein-metabolism/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology